D.E. Shaw & Co’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.46M Sell
68,292
-161,409
-70% -$10.5M ﹤0.01% 1500
2025
Q1
$15.4M Buy
229,701
+33,382
+17% +$2.23M 0.01% 777
2024
Q4
$10.9M Buy
196,319
+87,698
+81% +$4.85M 0.01% 959
2024
Q3
$6.48M Buy
108,621
+99,861
+1,140% +$5.96M 0.01% 1176
2024
Q2
$558K Buy
+8,760
New +$558K ﹤0.01% 2441
2022
Q2
Sell
-14,653
Closed -$412K 4126
2022
Q1
$412K Sell
14,653
-21,286
-59% -$599K ﹤0.01% 3303
2021
Q4
$1.66M Buy
35,939
+18,424
+105% +$849K ﹤0.01% 2481
2021
Q3
$575K Sell
17,515
-7,399
-30% -$243K ﹤0.01% 2779
2021
Q2
$873K Sell
24,914
-13,832
-36% -$485K ﹤0.01% 2586
2021
Q1
$1.4M Buy
38,746
+12,286
+46% +$444K ﹤0.01% 2008
2020
Q4
$768K Buy
+26,460
New +$768K ﹤0.01% 2138
2020
Q2
Sell
-16,523
Closed -$673K 2608
2020
Q1
$673K Sell
16,523
-20,482
-55% -$834K ﹤0.01% 2030
2019
Q4
$2.28M Buy
37,005
+2,756
+8% +$170K ﹤0.01% 1539
2019
Q3
$2.5M Buy
34,249
+18,892
+123% +$1.38M ﹤0.01% 1478
2019
Q2
$1.26M Buy
15,357
+8,255
+116% +$678K ﹤0.01% 1797
2019
Q1
$501K Buy
7,102
+1,308
+23% +$92.3K ﹤0.01% 2116
2018
Q4
$261K Buy
5,794
+700
+14% +$31.5K ﹤0.01% 2299
2018
Q3
$288K Buy
+5,094
New +$288K ﹤0.01% 2260
2017
Q1
Hold
0
2404
2016
Q4
Hold
0
2470
2016
Q3
Hold
0
2476
2016
Q2
Hold
0
2512
2015
Q3
Sell
-15,000
Closed -$931K 2538
2015
Q2
$931K Sell
15,000
-21,829
-59% -$1.35M ﹤0.01% 1886
2015
Q1
$2.3M Buy
36,829
+23,429
+175% +$1.47M ﹤0.01% 1290
2014
Q4
$756K Buy
+13,400
New +$756K ﹤0.01% 1829
2014
Q3
Sell
-13,039
Closed -$449K 2362
2014
Q2
$449K Buy
13,039
+3,699
+40% +$127K ﹤0.01% 1932
2014
Q1
$293K Buy
+9,340
New +$293K ﹤0.01% 2047
2013
Q3
Sell
-3,927
Closed -$24K 2371
2013
Q2
$24K Buy
+3,927
New +$24K ﹤0.01% 2324